title: Response to Comment on Schwartz et al. The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema. Diabetes Care 2016;39:179-186.
authors.affiliation: Main Line Health System, Wynnewood, PA, and University of Pennsylvania, Philadelphia, PA stschwar@gmail.com.
authors.forename: Stanley S
authors.initials: SS
authors.lastname: Schwartz
authors.affiliation: Division of Endocrinology, Diabetes and Bone Disease, Department of Medicine, Mount Sinai Hospital, New York, NY.
authors.forename: Solomon
authors.initials: S
authors.lastname: Epstein
authors.affiliation: Department of Medicine, Boston University School of Medicine, Boston, MA.
authors.forename: Barbara E
authors.initials: BE
authors.lastname: Corkey
authors.affiliation: Division of Human Genetics and Center for Applied Genomics, Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.
authors.forename: Struan F A
authors.initials: SF
authors.lastname: Grant
authors.affiliation: Emory University School of Medicine, Atlanta, GA.
authors.forename: James R
authors.initials: JR
authors.lastname: Gavin
authors.affiliation: Diabetes Nation, Sisters, OR.
authors.forename: Richard B
authors.initials: RB
authors.lastname: Aguilar
mesh_terms: D003924:Diabetes Mellitus, Type 2; D006801:Humans; D050417:Insulin-Secreting Cells